{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-179382","form_type":"8-K","ticker":"PSTV","cik":"0001095981","company_name":"PLUS THERAPEUTICS, INC.","filed_at":"2025-08-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.327458+00:00","generated_at":"2026-05-17T13:51:01.980386+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.7,"confidence":"high","headline":"Plus Therapeutics updates Nasdaq listing; panel grants continued listing with conditions","bullets":["Nasdaq panel granted continued listing; must demonstrate $2.5M stockholders' equity compliance by Aug 14, 2025.","Must also meet $1.00 bid price for 10 consecutive days by Sep 8, 2025.","Company reported stockholders' deficit of $23.6M as of March 31, 2025, triggering delisting notice.","Hearing held July 15, 2025; panel decision issued July 22, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-179382","json":"https://secwatch.observer/filing/0001193125-25-179382.json","markdown":"https://secwatch.observer/filing/0001193125-25-179382.md","text":"https://secwatch.observer/filing/0001193125-25-179382.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1095981/000119312525179382/0001193125-25-179382-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1095981/000119312525179382/d930191d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T13:51:01.980386+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}